Cystic Fibrosis Therapeutics size, Trends and Industry Analysis Cystic Fibrosis Therapeutics size, Trends and Industry Analysis

1
Cystic Fibrosis Therapeutics Market
Cystic Fibrosis Therapeutics Market Comprehensive
Study with Key Trends, Major Drivers and
Challenges
Sample
View Report
2
Cystic Fibrosis Therapeutics MarketOutlook,
Growth Factors, Industry Share, Size By 2030
Cystic Fibrosis (CF) is a genetic disease that
affects mainly the respiratory, digestive, and
reproductive systems. The disease is caused by a
mutation in the CFTR gene, which encodes for a
protein that regulates the transport of chloride
ions across cell membranes. There is no cure for
CF, but there are several therapeutics available
to manage the symptoms and slow the progression
of the disease. Some of the most commonly used CF
therapeutics are According to Straits Research
The global cystic fibrosis therapeutics market
size was valued at USD 6.33 billion in 2021 and
is expected to reach USD 13.88 billion in 2030
expanding at a CAGR of 9.12.
The CF therapeutics market is segmented by drug
class, including CFTR modulators, mucolytics,
antibiotics, pancreatic enzyme replacement
therapy, bronchodilators, and others. CFTR
modulators are the largest segment, accounting
for over half of the market share. Within the
CFTR modulator class, the combination drug
Lumacaftor/Ivacaftor has been the largest
contributor to the market revenue.
Geographically, the North American region
dominates the cystic fibrosis therapeutics
market, followed by Europe. The increasing
prevalence of cystic fibrosis, the high adoption
rate of novel therapies, and favorable
reimbursement policies are some of the key
factors driving the growth of the market in these
regions.
3

Cystic Fibrosis Therapeutics Market
CAGR 9.12 (2022-2030)
13.88 Billion
6.33 Billion
Request Sample
4
Cystic Fibrosis Therapeutics Market
A Summary of the Impact of COVID-19 on this
Market
Main Market Players Covered in This Report

• Vertex Pharmaceutical Incorporated
• Roche
• Nestle Health Science
• AbbVie
• Viatris Inc.
• Horizon Therapeutic Plc.
• Gilead Sciences
• Chiesi Farmacrutici
• Pharmaxis Ltd.

The appearance of COVID-19 has transported the
globe to a halt. We understand that this health
disaster has brought an unprecedented impact on
businesses across industries. However, this too
shall pass. Growing support from governments and
various companies can benefit in the fight
against this highly transmissible disease. There
are some businesses that are struggling and some
are thriving. General, almost every sector is
anticipated to be stuck by the pandemic
5
Cystic Fibrosis Therapeutics Market
The Cystic Fibrosis Therapeutics Market has been
segmented as below

• By Drug ClassPancreatic Enzyme Supplements,
  Mucolytics, Bronchodilators, CFTR ModulatorsBy
• By Route of Administration Oral Drugs, Inhaled
  Drugs
• By Regions- North America, Europe, Asia-Pacific,
  LAMEA

We are taking nonstop efforts to help your
business sustain and cultivate during COVID-19
pandemics. Based on our knowledge and expertise,
we will provide you an impact analysis of
coronavirus outbreaks across businesses to help
you prepare for the future.
Thanks for reading this article you can also get
distinct chapter-wise sections or region-wise
report versions like Asia, US, Europe, Africa,
etc.
6
About Straits Research
StraitsResearch.com is a leading market research
and market intelligence organization,
specializing in research, analytics, and advisory
services along with providing business insights
market research reports.